![David Mack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/07/2026
David H.
Mack is the founder of PMV Pharmaceuticals, Inc., founded in 2013, where the titles held include President, Chief Executive Officer & Director.
Dr. Mack is also the founder of EOS Biotechnology, Inc...
Current jobs include Director at Intradigm Corp.
since 2006, Director at Vitra Bioscience, Inc., and Director at ACMP IV LLC.
Former jobs include Chief Executive Officer & Director at Angiosyn, Inc. from 2003 to 2005; Director at Alta Partners Management Co. LP; Director at Proacta, Inc.; Director at Ceregene, Inc.; Independent Director at Aerie Pharmaceuticals, Inc. in 2013; Director at aTyr Pharma, Inc.; Director at Sutro Biopharma, Inc.; Director at Aduro BioTech, Inc. from 2019 to 2020; Non-Executive Director at Silence Therapeutics Plc from 2010 to 2013; Director at Pathwork Diagnostics, Inc.; Director at Proacta Therapeutics Ltd.; Head-Cancer Biology at Affymetrix, Inc. from 1994 to 1997; and Member-Polymerase Chain Reaction Invention at Cetus Corp.
Education includes a doctorate from The University of Chicago in 1992 and undergraduate studies at the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/04/2026 | 1.126.976 ( 2,11 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Fundador | 01/06/2013 |
ACMP IV LLC | Director/Miembro de la Junta | - |
Vitra Bioscience, Inc.
 Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Develops technologies for biological research and drug discovery | Director/Miembro de la Junta | - |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Director/Miembro de la Junta | 01/05/2006 |
| Empresas | Cargo | Fin |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 05/10/2020 |
| AERIE PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/12/2013 |
| SILENCE THERAPEUTICS PLC | Director/Miembro de la Junta | 26/06/2013 |
Angiosyn, Inc.
 Angiosyn, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products for controlling angiogenesis | Director Ejecutivo | 01/01/2005 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Fundador | 02/01/2003 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 20 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
Angiosyn, Inc.
Angiosyn, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products for controlling angiogenesis | Health Technology |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Health Technology |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for neurodegenerative disorders | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitra Bioscience, Inc.
Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Develops technologies for biological research and drug discovery | Health Technology |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostic tests for cancer | Health Technology |
Proacta Therapeutics Ltd.
 Proacta Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
ACMP IV LLC | |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
